Top

Reactions Weekly

Published in:

01-01-2021 | Acute Myeloid Leukemia | Case report

Gemtuzumab ozogamicin

Hyperbilirubinaemia and increased AST: 2 case reports

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Pena M, et al. Gemtuzumab ozogamicin at low doses does not produce significant toxicities during induction therapy and after hematopoietic stem cell transplantation in adults with acute myeloid leukemia. Bone Marrow Transplantation 54: 377-378 abstr. P361, 2019. Available from: URL: http://doi.org/10.1038/s41409-019-0559-4 [abstract]

Title: Gemtuzumab ozogamicin
Hyperbilirubinaemia and increased AST: 2 case reports
Publication date: 01-01-2021
Publisher: Springer International Publishing
Keywords: Acute Myeloid Leukemia
Gemtuzumab Ozogamicin
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-88887-7

2024 ASCO Annual Meeting

Springer Medicine

Gemtuzumab ozogamicin

Hyperbilirubinaemia and increased AST: 2 case reports

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Amiodarone

Enoxaparin-sodium

Empagliflozin

Immunosuppressants

Antifungals/potassium/potassium chloride

Mesalazine/prednisone